EE200100623A - Melatoniini terapeutiline kasutamine - Google Patents
Melatoniini terapeutiline kasutamineInfo
- Publication number
- EE200100623A EE200100623A EEP200100623A EEP200100623A EE200100623A EE 200100623 A EE200100623 A EE 200100623A EE P200100623 A EEP200100623 A EE P200100623A EE P200100623 A EEP200100623 A EE P200100623A EE 200100623 A EE200100623 A EE 200100623A
- Authority
- EE
- Estonia
- Prior art keywords
- melatonin
- therapeutic use
- therapeutic
- Prior art date
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
- 229960003987 melatonin Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13017199A IL130171A (en) | 1999-05-27 | 1999-05-27 | Melatonin for use in preventing and treating tardive dyskinesia, pharmaceutical preparations containing it and its use in the manufacture of medicines |
| PCT/IL2000/000296 WO2000072843A1 (en) | 1999-05-27 | 2000-05-24 | Therapeutic use of melatonin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200100623A true EE200100623A (et) | 2003-02-17 |
Family
ID=11072852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100623A EE200100623A (et) | 1999-05-27 | 2000-05-24 | Melatoniini terapeutiline kasutamine |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6566389B1 (ja) |
| EP (1) | EP1183024A4 (ja) |
| JP (1) | JP2003500446A (ja) |
| KR (1) | KR20020015329A (ja) |
| CN (1) | CN1176652C (ja) |
| AR (1) | AR036321A1 (ja) |
| AU (1) | AU775520B2 (ja) |
| BG (1) | BG106234A (ja) |
| BR (1) | BR0017329A (ja) |
| CA (1) | CA2374129A1 (ja) |
| CZ (1) | CZ20014190A3 (ja) |
| EA (1) | EA004057B1 (ja) |
| EE (1) | EE200100623A (ja) |
| HK (2) | HK1046089A1 (ja) |
| HU (1) | HUP0201405A3 (ja) |
| IL (1) | IL130171A (ja) |
| IS (1) | IS6172A (ja) |
| MX (1) | MXPA01012040A (ja) |
| NO (1) | NO319421B1 (ja) |
| NZ (1) | NZ515866A (ja) |
| PE (1) | PE20010129A1 (ja) |
| PL (1) | PL351885A1 (ja) |
| SK (1) | SK16402001A3 (ja) |
| TN (1) | TNSN00117A1 (ja) |
| TR (1) | TR200103418T2 (ja) |
| TW (1) | TWI236906B (ja) |
| UA (1) | UA71968C2 (ja) |
| UY (1) | UY26171A1 (ja) |
| WO (1) | WO2000072843A1 (ja) |
| ZA (1) | ZA200110436B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
| CA2556753C (en) * | 2004-02-20 | 2014-11-25 | Lifescape Biosciences Incorporated | Compositions and methods for sleep regulation |
| CN1299680C (zh) * | 2005-08-29 | 2007-02-14 | 陈彦方 | 一种治疗失眠的黑白制剂 |
| US7494674B2 (en) | 2006-09-22 | 2009-02-24 | Lapointe Andrew T | Nutraceutical with tart cherries and method of treatment therewith |
| WO2008116004A2 (en) | 2007-03-19 | 2008-09-25 | Vita Sciences, Llc | Transdermal patch and method for delivery of vitamin b12 |
| WO2008128166A1 (en) * | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
| US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
| US20100256215A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Menthol-Melatonin Dissolving Film |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| FR3000896B1 (fr) | 2013-01-14 | 2016-08-26 | Philippe Perovitch | Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil |
| US11071739B1 (en) | 2020-09-29 | 2021-07-27 | Genus Lifesciences Inc. | Oral liquid compositions including chlorpromazine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691324A (en) * | 1994-01-14 | 1997-11-25 | Sandyk; Reuven | Methods useful for the treatment of neurological and mental disorders related to deficient serotonin neurotransmission and impaired pineal melatonin functions |
| US6469044B1 (en) * | 1995-02-01 | 2002-10-22 | Neurim Pharmaceuticals (1991) Ltd. | Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies |
| AUPO274596A0 (en) * | 1996-10-04 | 1996-10-31 | Armstrong, Stuart Maxwell | Method for the treatment of neurological or neuropsychiatric disorders |
| AUPO588297A0 (en) * | 1997-03-26 | 1997-04-24 | Luminis Pty Limited | Mediation in melatonin production |
-
1999
- 1999-05-27 IL IL13017199A patent/IL130171A/en not_active IP Right Cessation
-
2000
- 2000-05-24 KR KR1020017014958A patent/KR20020015329A/ko not_active Application Discontinuation
- 2000-05-24 NZ NZ515866A patent/NZ515866A/en unknown
- 2000-05-24 SK SK1640-2001A patent/SK16402001A3/sk unknown
- 2000-05-24 MX MXPA01012040A patent/MXPA01012040A/es not_active Application Discontinuation
- 2000-05-24 PL PL00351885A patent/PL351885A1/xx not_active Application Discontinuation
- 2000-05-24 AU AU47756/00A patent/AU775520B2/en not_active Ceased
- 2000-05-24 TR TR2001/03418T patent/TR200103418T2/xx unknown
- 2000-05-24 EA EA200101240A patent/EA004057B1/ru not_active IP Right Cessation
- 2000-05-24 CN CNB008081069A patent/CN1176652C/zh not_active Expired - Fee Related
- 2000-05-24 WO PCT/IL2000/000296 patent/WO2000072843A1/en not_active Application Discontinuation
- 2000-05-24 EE EEP200100623A patent/EE200100623A/xx unknown
- 2000-05-24 BR BR0017329-0A patent/BR0017329A/pt not_active IP Right Cessation
- 2000-05-24 JP JP2000620955A patent/JP2003500446A/ja active Pending
- 2000-05-24 EP EP00929756A patent/EP1183024A4/en not_active Withdrawn
- 2000-05-24 HU HU0201405A patent/HUP0201405A3/hu unknown
- 2000-05-24 CZ CZ20014190A patent/CZ20014190A3/cs unknown
- 2000-05-24 US US09/979,583 patent/US6566389B1/en not_active Expired - Lifetime
- 2000-05-24 UA UA2001128828A patent/UA71968C2/uk unknown
- 2000-05-24 CA CA002374129A patent/CA2374129A1/en not_active Abandoned
- 2000-05-26 PE PE2000000503A patent/PE20010129A1/es not_active Application Discontinuation
- 2000-05-26 AR ARP000102569A patent/AR036321A1/es not_active Application Discontinuation
- 2000-05-26 UY UY26171A patent/UY26171A1/es unknown
- 2000-05-26 TN TNTNSN00117A patent/TNSN00117A1/fr unknown
- 2000-05-31 TW TW089110619A patent/TWI236906B/zh not_active IP Right Cessation
-
2001
- 2001-11-22 IS IS6172A patent/IS6172A/is unknown
- 2001-11-26 NO NO20015738A patent/NO319421B1/no unknown
- 2001-12-18 BG BG106234A patent/BG106234A/bg unknown
- 2001-12-20 ZA ZA200110436A patent/ZA200110436B/xx unknown
-
2002
- 2002-09-06 HK HK02106585.6A patent/HK1046089A1/zh unknown
- 2002-11-29 HK HK02108721.7A patent/HK1047048B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1637127T3 (da) | Terapeutisk mikroskum | |
| NO20021400D0 (no) | Terapeutiske konazolinderivater | |
| EE200100370A (et) | Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid | |
| NO20014858L (no) | Anvendelse av CYP2D6 inhibitorer i kombinasjonsterapi | |
| NO20014379D0 (no) | Anvendelse av Xenon for behandling av Neurointoksikasjoner | |
| NO20014560D0 (no) | Quinasoliner og terapautisk anvendelse derav | |
| NO20001962D0 (no) | Terapeutisk anvendelse av kinolinderivater | |
| PT1235558E (pt) | Agentes terapeuticos | |
| FI20000863A (fi) | Uusi hoitomenetelmä | |
| EE200100623A (et) | Melatoniini terapeutiline kasutamine | |
| PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
| NO20016301D0 (no) | Terapeutiske midler | |
| ID30381A (id) | Penggunaan arilalkanoilpiridazina | |
| EA199901044A1 (ru) | Аппликатор-массажер | |
| NO20023243D0 (no) | Ny terapeutisk anvendelse av enoxaparin | |
| FI991138A0 (fi) | Normobarisen hypoksian käyttö terapeuttisesti | |
| ID24439A (id) | Penggunaan tiazolidindion untuk pengobatan hiperglikemia | |
| ATE496631T1 (de) | Melanomtherapie | |
| UA3888S (uk) | Терапевтична лампа | |
| SE9904322D0 (sv) | Hjärtmassageapparat | |
| ID24521A (id) | Penggunaan tiazolidindion untuk pengobatan hiperglikemia | |
| SE9802023D0 (sv) | New therapeutic use | |
| ES1044621Y (es) | Tumbona perfeccionada |